David Khoury

Jul 19, 2023 | nature.com | Daniela Olivera Mesa |Jaspreet Toor |Oliver Watson |Peter Winskill |Gregory Barnsley |David Khoury | +2 more

DataWe used empirical estimates of vaccine effectiveness against what we term mild disease (positive polymerase chain reaction (PCR) tests including symptomatic cases and asymptomatic infections detected through screening in schools and workplaces), hospitalisations (defined as admission recorded in the Emergency Care Dataset within 14 days of a positive test) and death (within 28 days of a positive test) with the Delta and Omicron BA.1/BA.2 variants from England.